Press release
Choroidal Neovascularization Drug Market sizes and predictions for growth
This report studies the Choroidal Neovascularization Drug market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Choroidal Neovascularization Drug market by product type and application/end industries.
Request Sample Copy of the Report @ https://www.marketresearchreports.biz/sample/sample/1664144
The global Choroidal Neovascularization Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Choroidal Neovascularization Drug.
United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.
Complete Report Details @ https://www.marketresearchreports.biz/reports/1664144/choroidal-neovascularization-drug-report-market-research-reports
Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Choroidal Neovascularization Drug in these regions, from 2013 to 2025 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa
The major players in global and United States market, including
Cellphire, Inc.
Chrysalis BioTherapeutics, Inc.
Cleveland BioLabs, Inc.
Cumberland Pharmaceuticals, Inc.
Diffusion Pharmaceuticals Inc.
Eli Lilly and Company
GNI Group Ltd.
Humanetics Corporation
INSYS Therapeutics, Inc.
Meabco A/S
Neumedicines Inc.
Onconova Therapeutics, Inc.
PharmaIN Corporation
Pluristem Therapeutics Inc.
ProCertus BioPharm Inc.
RDD Pharma Ltd.
RedHill Biopharma Ltd.
RxBio, Inc.
Soligenix, Inc.
On the basis of product, the market is primarily split into
AVMOC-001
BB-3
BBT-007
DG-3
Entolimod
EWA-001
Others
On the basis on the end users/application, this report covers
Clinic
Hospital
Others
Request For TOC Report @ https://www.marketresearchreports.biz/reports/1664144/choroidal-neovascularization-drug-report-market-research-reports/toc
Table of Contents
2018-2025 Choroidal Neovascularization Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
2 Choroidal Neovascularization Drug Market Overview
2.1 Choroidal Neovascularization Drug Product Overview
2.2 Choroidal Neovascularization Drug Market Segment by Type
2.2.1 AVMOC-001
2.2.2 BB-3
2.2.3 BBT-007
2.2.4 DG-3
2.2.5 Entolimod
2.2.6 EWA-001
2.2.7 Others
2.3 Global Choroidal Neovascularization Drug Product Segment by Type
2.3.1 Global Choroidal Neovascularization Drug Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
2.3.2 Global Choroidal Neovascularization Drug Sales (K Pcs) and Market Share (%) by Type (2013-2018)
2.3.3 Global Choroidal Neovascularization Drug Revenue (Million USD) and Market Share (%) by Type (2013-2018)
2.3.4 Global Choroidal Neovascularization Drug Price (USD/Pcs) by Type (2013-2018)
2.4 United States Choroidal Neovascularization Drug Product Segment by Type
2.4.1 United States Choroidal Neovascularization Drug Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
2.4.2 United States Choroidal Neovascularization Drug Sales (K Pcs) and Market Share by Type (2013-2018)
2.4.3 United States Choroidal Neovascularization Drug Revenue (Million USD) and Market Share by Type (2013-2018)
2.4.4 United States Choroidal Neovascularization Drug Price (USD/Pcs) by Type (2013-2018)
3 Choroidal Neovascularization Drug Application/End Users
3.1 Choroidal Neovascularization Drug Segment by Application/End Users
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Choroidal Neovascularization Drug Product Segment by Application
3.2.1 Global Choroidal Neovascularization Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.2.2 Global Choroidal Neovascularization Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Choroidal Neovascularization Drug Product Segment by Application
3.3.1 United States Choroidal Neovascularization Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
3.3.2 United States Choroidal Neovascularization Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact Us
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: https://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Choroidal Neovascularization Drug Market sizes and predictions for growth here
News-ID: 1027678 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Choroidal
Choroidal Neovascularization Market to Register Steady Expansion During 2017-202 …
Choroidal neovascularization is a disease that results in the formation of new blood vessels in the brunch membrane of choroid layer of eye. It occurs due to the secretion of excess amount of vascular endothelial growth factor. It can also occur, when a patient suffers with wet macular degeneration. Also, choroidal neovascularization can be caused due to genetic diseases such as optic disc drusen and pseudoxanthoma elasticum. It is also…
Choroidal Neovascularization Market Market Opportunities in the by 2025
Choroidal neovascularization is a disease that results in the formation of new blood vessels in the brunch membrane of choroid layer of eye. It occurs due to the secretion of excess amount of vascular endothelial growth factor. It can also occur, when a patient suffers with wet macular degeneration. Also, choroidal neovascularization can be caused due to genetic diseases such as optic disc drusen and pseudoxanthoma elasticum.
It is also…
Choroidal Neovascularization Assessment and Therapeutics Pipeline Review H1 2018
Summary
Choroidal neovascularization (CNV) involves the growth of new blood vessels that originate from the choroid Symptoms include painless loss of vision, metamorphopsia, and color disturbances. Treatment includes ant-VEGF agents, laser photocoagulation and photodynamic therapy.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Choroidal Neovascularization - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Choroidal Neovascularization (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of…
CNV (Choroidal NeoVascularization) Market: Business Intelligence & Market Insigh …
Choroid is the part of eye that lies in between the retina (vision sensory area) and the sclera (the outer layer of the eye), this area consist of blood vessels that supply nutrients to the retinal part of our eye. Choroidal NeoVascularization (CNV) is a disease, which is characterized by the formation of new blood vessels that arise either due to the presence of Vascular Endothelial Growth Factors (VGEF) or…
Choroidal Neovascularization Market Report -Pipeline Review, H2 2017
"The Latest Research Report Choroidal Neovascularization-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Choroidal Neovascularization Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Choroidal Neovascularization-Pipeline Review, H2 2017, provides an overview of the Choroidal Neovascularization (Ophthalmology) pipeline landscape.
Choroidal neovascularization (CNV) involves the growth of new blood vessels that originate from the choroid Symptoms include painless…
Competitive Landscape for CNV Choroidal NeoVascularization Market by Segments - …
The only successful treatment option that is available commercially in the market for CNVs include intravitreal (direct to the eye) injections of anti-VEGF drugs to control the neovascularization and reduce the fluid accumulated. The most common anti-VGEF compounds are Ranibizumab (Trade name: Lucentis), Bevacizumab (Trade name: Avastin) and the novel drug Pegaptanib (Trade name: Macugen). These drugs belong to a class called anti-angiogenic drugs, their primary objective being the inhibition…
